GAO should study if TrumpRx saved people money, lawmaker says| STAT

Ed’s tales discover prescription drug pricing, affordability and entry, as effectively points surrounding patents, litigation, and laws. He’s additionally the creator of the morning Pharmalittle e-newsletter and the afternoon Pharmalot e-newsletter.

A Home lawmaker requested the Authorities Accountability Workplace to overview whether or not the TrumpRx platform has saved People any cash.

In an Oct. 27 letter, Frank Pallone (D-N.J.), the rating member of the Home Committee on Vitality and Commerce, mentioned the White Home has made “sweeping statements” that the web site has helped People save $700 million because it was launched in February. TrumpRx doesn’t promote or dispense medicine however directs customers to coupons or hyperlinks for reductions.

Nevertheless, Pallone mentioned the Trump administration has did not “disclose key info” that may assist consider whether or not the platform has offered “any significant monetary profit,” he wrote. Particularly, he cited the dearth of particulars about most-favored nation agreements the White Home reached with greater than two dozen drugmakers.